The US health regulator has pulled up Jagsonpal Pharmaceuticals for significant manufacturing lapses at its Rajasthan-based active pharmaceutical ingredients (APIs) plant.

Corcept Therapeutics Incorporated (NASDAQ:CORT) is a biopharmaceutical company that develops and commercializes therapies ...

The Trump Administration is calling for a report "assess[ing] the prevalence of and threat" of several drugs, including ...

Recent health news highlights disruptions in HIV and malaria supply chains due to a U.S. aid freeze, FDA's approval of a new ...

The current state of health services highlights crucial sectors facing disruptions and developments, from US foreign aid freezes affecting disease control supply chains, to the FDA's actions on new ...

The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, ...

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...

The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, ...

Esperion Therapeutics has two approved LDL-C lowering therapies, Nexletol and Nexlizet, but lacks a strong pipeline for future growth.

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

In Robert F. Kennedy Jr.’s first interview as secretary of the Department of Health and Human Services, he made multiple ...

The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli, or chenodiol, to treat Cerebrotendinous Xanthoma, the agency said Friday. "FDA Approves Mirum Pharmaceuticals Treatment for ...